Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/16/2026

1. SPY
2. USO
3. NVDA
4. INTC
5. JPM
6. JBHT
7. QQQ
8. BBNX
9. FPS
10. CRM

Go back to Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
(AMEX: IVBIY) Delayed: 54.29 --0 (-0%)
Previous Close $54.29    52 Week High $ 
Open $54.29    52 Week Low $ 
Day High $54.29    P/E N/A 
Day Low $54.29    EPS $ 
Volume 4       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1144.38 +8.27 (0.73%)
Previous Close $1136.11    52 Week High $88.16 
Open $1137.31    52 Week Low $67.88 
Day High $1151.23    P/E 264.90 
Day Low $1134.72    EPS $4.32 
Volume 460,120